DeucravacitinibSLE
…ectives Effective, well-tolerated therapies are needed for SLE. Deucravacitinib is an oral, selective tyrosine kinase 2 (TYK2) inhibitor under …
2articles mentioning drugs
12drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: deucravacitinib ×
deucravacitinib
This drug is selected. Its supporting articles are shown below.
Articles mentioning deucravacitinib
2 articles · page 1 of 1deucravacitinibianalumabupadacitinibtelitaciceptBaricitinibelsubrutinibsystemic lupus erythematosus
…oral small molecule kinase inhibitors, such as upadacitinib and deucravacitinib, as potential additions to standard of care in SLE, considering…